As of 2026-03-29, the Fair Value of Prelude Therapeutics Inc (PRLD) is -2.87 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.05 USD, the upside of Prelude Therapeutics Inc is -194.15%.
With the market price of 3.05 USD and our fair value calculation, Prelude Therapeutics Inc (PRLD) is not a good investment. Investing in PRLD stocks now will result in a potential loss of 194.15%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -111.69 | -115.44 | -121.83 | -127.17 | -99.50 | -115.13 |
| YoY growth | -96.19% | -3.36% | -5.54% | -4.38% | 21.76% | -17.54% |
| Market Cap (mil) | 192.15 |
| P/E | |
| Forward P/E |
| EPS | -0.57 |
| Avg earnings growth rate | -17.54% |
| TTM earnings | -36.18 |